TIMM50 and Global developmental delay: MGCA9 is a genetically heterogeneous disorder characterized by early‐onset seizures, developmental delay, intellectual disability, hypotonia, spasticity, increased serum lactate, and 3‐methylglutaconic aciduria, in which the clinical features are consistent with clinical characteristics of our cohort.